GIOPEM 500MG INJECTION
Giopem 500mg Injection is used in the treatment of non-small cell lung cancer and malignant pleural mesothelioma.
Giopem 500mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, loss of appetite, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver and blood uric acid levels.
Before taking it, tell your doctor if have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Benefits of Giopem Powder for Injection
In Non-small cell lung cancer
Side effects of Giopem Powder for Injection
Common side effects of Giopem
- Nausea
- Vomiting
- Sore throat
- Loss of appetite
- Stomatitis (Inflammation of the mouth)
- Hair loss
- Low blood platelets
- Rash
- Fatigue
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Neuropathy
Safety advice
Giopem 500mg Injection may make you feel tired and this may affect your ability to drive.
Use of Giopem 500mg Injection is not recommended in patients with moderate to severe kidney disease.